Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001193125-26-318103

Director acquired 8,463 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Postma Robert W Director 2026-07-23 Grant or award +8,463 $1.92 $16,249 58,609 D: show line 1 in the form
Loading xslF345X06/ownership.xml…